Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV536
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,315
Award facts
- Contract value 100% obligated
- $31,315.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,315.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This non-set-aside award was completed on January 15, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, continues to demonstrate its capability as a critical federal vendor through competitive procurement. The company supplies an extensive portfolio of pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for Zepbound, a diabetes medication, reflects the company's role in fulfilling DLA's medical supply chain requirements and supports the broader federal healthcare mission for military and defense personnel.
Quick answers
Who was awarded contract SPE2DR26FV536?
SPE2DR26FV536 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FV536 worth?
The government has obligated $31,315 on SPE2DR26FV536.
Is contract SPE2DR26FV536 an order under another contract?
Yes. SPE2DR26FV536 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV536 competed?
The extent of competition for SPE2DR26FV536 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award